MedTrace Logo

DCM Precision Medicine Study

NCT03037632 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6500

Last updated 2025-07-30

No results posted yet for this study

Summary

The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.

Conditions

  • Idiopathic Dilated Cardiomyopathy

Interventions

BEHAVIORAL

Family Heart Talk Booklet

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Human Genome Research Institute (NHGRI)

    collaborator NIH

  • Ray Hershberger

    lead OTHER

Principal Investigators

  • Ray Hershberger, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-07
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037632 on ClinicalTrials.gov